Hjem › Øcelleadenom › Illinois › Chicago
Øcelleadenom kliniske forsøg i Chicago, IL
4 studier for Øcelleadenom søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RekruttererFase 3
- Investigative Site, Chicago
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RekruttererFase 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130), Chicago
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
RekruttererFase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RekruttererFase 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Øcelleadenom forsøg i andre byer
- Rochester, MN5 studier
- Los Angeles, CA5 studier
- St. Louis, MO5 studier
- Phoenix, AZ4 studier
- Salt Lake City, UT4 studier
- Columbus, OH4 studier
- Washington, DC4 studier
- Lexington, KY4 studier
- Portland, OR4 studier
- Jacksonville, FL3 studier
- Irvine, CA3 studier
- Philadelphia, PA3 studier
Andre studier i Chicago
- Ikke-småcellet lungecancer61 studier
- Brystkræft58 studier
- Kræft (alle typer)51 studier
- Metastatisk cancer45 studier
- Prostatakræft45 studier
- Overvægt41 studier
- Lungecancer41 studier
- Ægstockræft36 studier
- Slagtilfælde34 studier
- Colorektal kræft33 studier
- Hjertesvigt31 studier
- Overvægt28 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.